Literature DB >> 9158736

The role of O-acetylation in the metabolism of peptidoglycan in Providencia stuartii.

K G Payie1, H Strating, A J Clarke.   

Abstract

The gentamicin 2'-N-acetyltransferase [EC 2.3.1.59; AAC(2')-Ia] of Providencia stuartii was shown to contribute to the O-acetylation of peptidoglycan and mutants that either under- or overexpress the aac(2')-Ia gene was characterized phenotypically to possess either lower or higher levels of peptidoglycan O-acetylation, respectively, compared to the wild-type. These mutants were subjected to scanning electron microscopy. P. stuartii PR100, with 42-44% peptidoglycan O-acetylation compared to 54% for the wild-type, appeared as irregular rods. In direct contrast, strains PR50.LM3 and PR51, with increased levels of peptidoglycan O-acetylation (63 and 65%, respectively), appeared as coccobacilli or chain formers, respectively. Zymogram analysis of the autolysins produced by another member of the closely related Proteeae group of bacteria, Proteus mirabilis, indicated the presence of three classes of enzymes: one that acts preferentially on native, O-acetylated peptidoglycan, a second that hydrolyses non-O-acetylated peptidoglycan, and a third that is not distinguished by the two forms of substrate. On the basis of the apparent morphological changes directly related to levels of O-acetylation combined with the presence of different classes of autolysins, a model is proposed that invokes the role of this modification in the control of autolysins for the maintenance of the structure of the peptidoglycan sacculus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9158736     DOI: 10.1089/mdr.1996.2.135

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  9 in total

1.  O-acetylation of peptidoglycan in gram-negative bacteria: identification and characterization of peptidoglycan O-acetyltransferase in Neisseria gonorrhoeae.

Authors:  Patrick J Moynihan; Anthony J Clarke
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

2.  Characterization of gentamicin 2'-N-acetyltransferase from Providencia stuartii: its use of peptidoglycan metabolites for acetylation of both aminoglycosides and peptidoglycan.

Authors:  K G Payie; A J Clarke
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

3.  Overexpression and characterization of the chromosomal aminoglycoside 2'-N-acetyltransferase of Providencia stuartii.

Authors:  K Franklin; A J Clarke
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

4.  Peptidoglycan O acetylation and autolysin profile of Enterococcus faecalis in the viable but nonculturable state.

Authors:  John M Pfeffer; Hendrik Strating; Joel T Weadge; Anthony J Clarke
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

5.  CpsY influences Streptococcus iniae cell wall adaptations important for neutrophil intracellular survival.

Authors:  Jonathan P Allen; Melody N Neely
Journal:  Infect Immun       Date:  2012-02-21       Impact factor: 3.441

Review 6.  Small-Molecule Acetylation by GCN5-Related N-Acetyltransferases in Bacteria.

Authors:  Rachel M Burckhardt; Jorge C Escalante-Semerena
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-15       Impact factor: 11.056

Review 7.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance.

Authors:  Laurent Hébert; Pascal Courtin; Riccardo Torelli; Maurizio Sanguinetti; Marie-Pierre Chapot-Chartier; Yanick Auffray; Abdellah Benachour
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

9.  Identification of a new family of enzymes with potential O-acetylpeptidoglycan esterase activity in both Gram-positive and Gram-negative bacteria.

Authors:  Joel T Weadge; John M Pfeffer; Anthony J Clarke
Journal:  BMC Microbiol       Date:  2005-08-19       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.